Dicyclohexylurea
Names | |
---|---|
IUPAC name
1,3-dicyclohexylurea | |
Identifiers | |
ChEMBL | ChEMBL1458 |
ChemSpider | 4126 |
| |
Jmol-3D images | Image |
PubChem | 4277 |
| |
Properties | |
Molecular formula |
C13H24N2O |
Molar mass | 224.34 g·mol−1 |
Melting point | 230 to 233 °C (446 to 451 °F; 503 to 506 K) |
Hazards | |
MSDS | External MSDS |
S-phrases | S24/25 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
verify (what is: / ?) | |
Infobox references | |
Dicyclohexylurea is an organic compound, specifically, a urea. It is the byproduct of the reaction of dicyclohexylcarbodiimide with amines or alcohols. It may be prepared by the reaction of cyclohexylamine and S,S-dimethyl dithiocarbonate.[1] 1,3-Dicyclohexyl urea (DCU) is a potent soluble epoxide hydrolase (sEH) inhibitor. It has been shown to lower systemic blood pressure by 22 ± 4 mmHg in SHR [2]
References
- ↑ Man-kit Leung, Jun-Liang Lai, King-Hang Lau, Hsiao-hua Yu, and Hsiang-Ju Hsiao (1996). "S,S-Dimethyl Dithiocarbonate: A Convenient Reagent for the Synthesis of Symmetrical and Unsymmetrical Ureas". The Journal of Organic Chemistry 61 (12): 4175–4179. doi:10.1021/jo9522825. PMID 11667305.
- ↑ Sarbani Ghosh, Po-Chang Chiang, Jan L. Wahlstrom, Hideji Fujiwara, Jon G. Selbo andSteven L. Roberds (2008). "Oral Delivery of 1,3-Dicyclohexylurea Nanosuspension Enhances Exposure and Lowers Blood Pressure in Hypertensive Rats". Basic & Clinical Pharmacology & Toxicology 102 (5): 453–458. doi:10.1111/j.1742-7843.2008.00213.x.